IP Library Assignment 055042/0165
Patent Assignment
Reel/Frame 055042/0165

Change of Name

Recorded: 2021-01-20 Pages: 3
Assignor
MENLO THERAPEUTICS INC.
Executed: 2020-09-04
Assignee
VYNE THERAPEUTICS INC.
520 U.S. HIGHWAY 22, SUITE 204, BRIDGEWATER, NEW JERSEY, 08807
Covered Property (1)
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 8,906,951 →
Application: 13/925,509 →
Publication: US 2014/0378521
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 25, 2013
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 030681/0886 →
Change of Name Jul 6, 2016
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 039197/0765 →
Patent Security Agreement Mar 9, 2020
From: MENLO THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 052130/0980 →
Release of Security Interest Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057531/0986 →